489sek
1,8 %
Date:2026-08-28Time:18:00:00Latest report:Q2-2026List:First NorthTicker:NANEXA
Market Cap:933 msekEnterprise Value:881 msekNet Sales:33,9 msekEarnings:-24,6 msekEmployees:0ISIN:SE0007074166

Ratios

10-year key figure history for Nanexa turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Nanexa with index and moving average MA50 and MA200.

Stockprice:4,89
MA50:4,05
MA200:3,63
Price/MA200:34,7 %
RSI (14):65,5
Price/MA50:20,7 %

Description

Nanexa is a drug delivery company with a proprietary platform used for the formulation of injectable depot drugs that create a supply of drugs to the blood. The company's technology is based on encapsulating drug particles with a thin shell and creating opportunities for pharmaceutical companies to develop new products. Nanexa has collaborations with several pharmaceutical companies, mainly around the Nordic market.

Medical Equipment